Chinese drug developer XTalPi surges on US$6 billion deal
- Posted on August 6, 2025
- By South China Morning Post
- 1 Views
Chinese drug developer XTalPi surges on US$6 billion deal
Deal with DoveTree, established by Harvard professor Gregory Verdine, adds to growing list of licensing tie-ups with Chinese firms.
